DIAGNOS Announces closing of Private Placement

BROSSARD, QUEBEC--(Marketwired - April 27, 2017) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces that it has completed a private placement ("Private Placement"), initially announced on April 13, 2017, of 261 units (each a "Unit") for an aggregate value of $2,610,000 of which gross cash proceeds amount to $2,460,000 following the conversion of one outstanding short term loan into 15 Units representing $150,000.